Layrek Clinical Research | Tulsa, OK logo

Layrek Clinical Research | Tulsa, OK

Research site
Location
10505 East 91st Street Suite 202, Tulsa, Oklahoma, United States of America
Site insights

Top conditions

Fibrosis (2 trials)

Pulmonary Fibrosis (2 trials)

Idiopathic Pulmonary Fibrosis (1 trial)

Top treatments

BMS-986278

Data sourced from clinicaltrials.gov

Trials

2 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.

Enrolling
Idiopathic Pulmonary Fibrosis
Drug: BMS-986278 Placebo
Drug: BMS-986278

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Enrolling
Progressive Pulmonary Fibrosis
Drug: BMS-986278 Placebo
Drug: BMS-986278

Trial sponsors

Bristol-Myers Squibb (BMS) logo

Bristol-Myers Squibb (BMS) (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems